Targeted therapies selected based on multigene panel improved outcomes for patients with hard-to-treat cancers
The progression-free survival rate (PFS) in cancer patients treated with targeted therapies (identified using a multigene panel test on their tumor samples) was significantly higher than the PFS in these patients when they ...
Apr 3, 2017
